Polyacid-based composite membrane electrode material for sensing L-tyrosine
An electrode material and composite membrane technology, which is applied in the field of multi-acid-based composite membrane electrode materials, can solve problems such as narrow linear range, low stability, and complicated preparation process, and achieve a wide linear range, good stability, and simple preparation methods. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0020] Embodiment 1: This embodiment is a multi-acid-based composite membrane electrode material for sensing L-tyrosine. It is an ionic liquid function doped by an ITO electrode and a phosphorus molybdenum vanadium heteropolyacid externally loaded on the ITO electrode. Composed of a carbon nanotube composite film, the ITO electrode layer is followed by a polyethyleneimine layer (PEI), a phosphorus-molybdenum-vanadium heteropolyacid-doped ionic liquid-functionalized carbon nanotube layer, in which phosphorus-molybdenum-vanadium heteropolyacid Multi-acid-doped ionic liquid-functionalized carbon nanotube layer is a multilayer cycle with a cycle number of 8, denoted as PEI / [P 2 Mo 16 V 2 / BMIMBr-CNTs] 8 .
specific Embodiment approach 2
[0021] Specific embodiment two: a kind of preparation method of the polyacid based composite membrane electrode material for sensing L-tyrosine is carried out according to the following steps:
[0022] 1. P 2 Mo 16 V 2 Solution preparation:
[0023] ① Weigh P with an analytical balance 2 Mo 16 V 2 Heteropoly acid 17mg~19mg, under the condition of magnetic stirring with a stirring speed of 40r / min~60r / min, Dawson type polyoxometalate P 2 Mo 16 V 2 Dissolve in 6mL deionized water, stir for 10min to obtain solution A;
[0024] ② Transfer solution A to 10mL vial B;
[0025] P in solution A described in step ① 2 Mo 16 V 2 The mass ratio of heteropoly acid to deionized water is 17~19:6;
[0026] The ratio of the volume of solution A and vial B described in step one 2. is 3: 5;
[0027] Two, the preparation of BMIMBr-CNTs solution:
[0028] ① Mix 0.2g of CNTs and 0.3g~0.5g of BMIMBr directly in a mortar, and grind for 30min to obtain a uniform paste A;
[0029] ②Add 3...
specific Embodiment approach 3
[0041] Specific implementation mode three: the difference between this implementation mode and specific implementation modes one to two is: step one described in ①
[0042] Dawson-type polyoxometalates P 2 Mo 16 V 2 The dosage is 18mg. Other steps and parameters are the same as those in the specific embodiment 1 to 2.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



